// App-Quantinova.ai

P2-09-14 : Association between BMI and residual estradiol levels in post-menopausal women using adjuvant letrozole: Results of a prospective study

Researchers

Presenter

  • DW Cescon

Principal Investigators

  • M Ennis

  • KI Pritchard

  • C Townsley

  • D Warr

  • C Elser

  • L Rao

  • V Stambolic

  • S Sridhar

  • PJ Goodwin

Medical Centers

  • Womens College Hospital, Toronto, ON, Canada

  • The Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada

  • Applied Statistician, Markham, ON, Canada

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • C reactive protein

  • Estradiol

Drug/Treatment

  • Anastrozole

  • Ergocalciferol

  • Alora

  • Letrozole

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved